604 related articles for article (PubMed ID: 33467883)
1. Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
Wang L; Ye Z; Jang YY
Exp Biol Med (Maywood); 2021 Apr; 246(7):861-875. PubMed ID: 33467883
[TBL] [Abstract][Full Text] [Related]
2. Genome editing in pluripotent stem cells: research and therapeutic applications.
Deleidi M; Yu C
Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
[TBL] [Abstract][Full Text] [Related]
3. Organoid technologies meet genome engineering.
Nie J; Hashino E
EMBO Rep; 2017 Mar; 18(3):367-376. PubMed ID: 28202491
[TBL] [Abstract][Full Text] [Related]
4. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology.
Kim J; Koo BK; Yoon KJ
Viruses; 2019 Jan; 11(2):. PubMed ID: 30704043
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of human pluripotent stem cell derived lung organoids.
Dye BR; Hill DR; Ferguson MA; Tsai YH; Nagy MS; Dyal R; Wells JM; Mayhew CN; Nattiv R; Klein OD; White ES; Deutsch GH; Spence JR
Elife; 2015 Mar; 4():. PubMed ID: 25803487
[TBL] [Abstract][Full Text] [Related]
6. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
[TBL] [Abstract][Full Text] [Related]
7. Kidney organoids-a new tool for kidney therapeutic development.
Bonventre JV
Kidney Int; 2018 Dec; 94(6):1040-1042. PubMed ID: 30466559
[TBL] [Abstract][Full Text] [Related]
8. Genome engineering of stem cell organoids for disease modeling.
Sun Y; Ding Q
Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
[TBL] [Abstract][Full Text] [Related]
9. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
Hirshorn ST; Steele N; Zavros Y
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
[TBL] [Abstract][Full Text] [Related]
10. A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.
Li M; Suzuki K; Kim NY; Liu GH; Izpisua Belmonte JC
J Biol Chem; 2014 Feb; 289(8):4594-9. PubMed ID: 24362028
[TBL] [Abstract][Full Text] [Related]
11. Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells.
Takasato M; Little MH
Methods Mol Biol; 2017; 1597():195-206. PubMed ID: 28361319
[TBL] [Abstract][Full Text] [Related]
12. Gene-Edited Fluorescent and Mixed Cerebral Organoids.
Bachmann L; Gallego Villarejo L; Heinen N; Marks D; Peters M; Müller T
CRISPR J; 2022 Feb; 5(1):53-65. PubMed ID: 35099270
[TBL] [Abstract][Full Text] [Related]
13. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
14. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.
Whiteley JT; Fernandes S; Sharma A; Mendes APD; Racha V; Benassi SK; Marchetto MC
Stem Cell Reports; 2022 Feb; 17(2):187-210. PubMed ID: 35063127
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.
Chun YW; Durbin MD; Hong CC
Curr Cardiol Rep; 2018 Apr; 20(6):38. PubMed ID: 29666931
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids.
Hendriks D; Clevers H; Artegiani B
Cell Stem Cell; 2020 Nov; 27(5):705-731. PubMed ID: 33157047
[TBL] [Abstract][Full Text] [Related]
18. Kidney Organoids: A Translational Journey.
Morizane R; Bonventre JV
Trends Mol Med; 2017 Mar; 23(3):246-263. PubMed ID: 28188103
[TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cells Meet Genome Editing.
Hockemeyer D; Jaenisch R
Cell Stem Cell; 2016 May; 18(5):573-86. PubMed ID: 27152442
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]